Poseida Therapeutics, Inc. revenue breakdown overview

Poseida Therapeutics, Inc. revenue for the last year amounted to 64.70 M USD, the most of which — 64.70 M USD — came from its highest performing source at the moment, Cell and Gene Therapies, the year earlier bringing 130.49 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Poseida Therapeutics, Inc. 64.70 M USD, and the year before that — 130.49 M USD.